Interestingly, the authors found that metformin cotreatment significantly reduced IL-6 secretion in the cisplatin-stimulated MRC5 fibroblast cell line and fibroblast-facilitated tumor growth when cocultured with the ovarian cancer cell line SKOV3, as well as in murine xenograft models. This evidence concerns the gene IL6 and ovarian cancer.